Anvisa approves the first biosimilar monoclonal antibody based on comparability in brazil

Teixeira, Fábio Vieira; Kotze, Paulo Gustavo; Damião, Adérson Omar Mourão Cintra

Teixeira, Fábio Vieira; Kotze, Paulo Gustavo; Damião, Adérson Omar Mourão Cintra.

Teixeira, Fábio Vieira; s.af
Kotze, Paulo Gustavo; s.af
Damião, Adérson Omar Mourão Cintra; s.af

Arq. gastroenterol ; 53(2): 60-61, April.-June 2016.

Article in English | LILACS | ID: lil-783814

Subject(s)

Humans; Gastrointestinal Agents; Drug Approval; Biosimilar Pharmaceuticals; Infliximab; Antibodies, Monoclonal; Brazil; Inflammatory Bowel Diseases; Government Agencies

Biosimilar pharmaceuticals; Colite ulcerativa; Crohn disease; Doença de Crohn; Medicamentos biossimilares; Ulcerative colitis

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Gastrointestinal Agents / Drug Approval / Biosimilar Pharmaceuticals / Infliximab / Antibodies, Monoclonal Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Arq. gastroenterol Journal subject: Gastroenterology Year: 2016 Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google